Insider Trading June 17, 2026 01:01 PM

Marathon Bancorp CEO Acquires Additional Equity Stake Amid Ongoing Share Repurchase Initiative

Executive increases direct ownership by $14,550 as company launches first buyback program since 2025 capital raise

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
MBBC

Nicholas W. Zillges, President and Chief Executive Officer of Marathon Bancorp, Inc., executed a direct equity acquisition on June 16, 2026, purchasing 970 shares of the company's common stock at a unit price of $15.00, totaling $14,550. Following this transaction, Mr. Zillges' direct common stock holdings stand at 57,205 shares. This acquisition occurs against a backdrop of significant stock price appreciation, with shares delivering a 50.55% return over the trailing twelve months, despite valuation metrics indicating potential overvaluation relative to fair value. Concurrently, Marathon Bancorp has initiated a stock repurchase program targeting up to 146,931 shares, representing approximately 5% of outstanding equity, marking the company's first such initiative since its April 2025 capital restructuring.

Marathon Bancorp CEO Acquires Additional Equity Stake Amid Ongoing Share Repurchase Initiative
MBBC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Marathon Bancorp CEO Nicholas Zillges purchased 970 shares at $15.00 per share, increasing his direct holdings to 57,205 shares, reflecting continued executive confidence in the company's long-term prospects.
  • The company has launched a new stock repurchase program for up to 146,931 shares, representing 5% of outstanding equity, marking its first buyback since the April 2025 capital raise.
  • Despite a 50.55% stock price return over the past year, valuation metrics indicate the stock may be overvalued relative to its fair value, presenting a divergence between price momentum and fundamental valuation.

Nicholas W. Zillges, serving as President and Chief Executive Officer of Marathon Bancorp, Inc. (NASDAQ:MBBC), has increased his direct equity position in the company. On June 16, 2026, Mr. Zillges acquired 970 shares of Marathon Bancorp common stock. The transaction was executed at a price of $15.00 per share, resulting in a total investment value of $14,550.

Post-transaction, Mr. Zillges holds 57,205 shares of common stock directly. This ownership structure includes restricted stock units that vest at a rate of 20% annually. The first tranche of restricted stock began vesting on June 28, 2023, while a subsequent tranche is scheduled to commence vesting on June 15, 2027.

Beyond direct holdings, Mr. Zillges maintains indirect equity exposure through multiple retirement and employee savings vehicles. These include 51,160 shares held within a 401(k) plan, 604 shares within an Individual Retirement Account (IRA), and 4,429 shares within an Employee Stock Ownership Plan (ESOP).

Mr. Zillges also maintains a substantial portfolio of derivative securities in the form of stock options. He holds options for 29,994 shares with an exercise price of $8.13. These options commenced vesting at a rate of 20% per year on June 28, 2023, and are scheduled to expire on June 28, 2032.

Additionally, Mr. Zillges holds options for 3,000 shares at an exercise price of $6.48. These options began vesting at 20% per year on May 16, 2024, and will expire on May 16, 2033.

A third tranche of options covers 42,335 shares with an exercise price of $14.55. These options are set to begin vesting at a rate of 20% per year on June 15, 2027, and will expire on June 15, 2036.

The insider acquisition occurs as Marathon Bancorp shares have demonstrated significant price momentum, delivering a 50.55% return over the past year. Despite this performance, valuation analysis suggests the stock is currently trading above its fair value, placing it within categories of overvalued equities. At the time of reporting, Marathon Bancorp shares were trading at $13.88, with a total market capitalization of $44.2 million.

In a concurrent development, Marathon Bancorp has announced a stock repurchase program authorizing the buyback of up to 146,931 shares of common stock. This volume represents approximately 5% of the company's outstanding shares. The announcement marks the firm's first stock repurchase program since completing its second step conversion and related stock offering in April 2025.

The repurchase initiative was communicated via press release, highlighting the strategic nature of the move. This action is framed as part of Marathon Bancorp's ongoing financial strategies, specifically focusing on the management of share capital. The program reflects the company's current approach to shareholder value management.

Market participants and analysts are expected to monitor the execution and impact of this repurchase program closely. The initiative represents a significant step in the company's capital allocation framework and will likely influence perceptions of the firm's financial standing and market valuation.

Risks

  • Valuation disconnect: Analysts note the stock is overvalued relative to fair value, suggesting potential downside risk if the market corrects the price to align with intrinsic valuation metrics.
  • Execution uncertainty: The impact of the new share repurchase program on financial standing and market perception remains to be seen, as the program's effectiveness depends on market conditions and execution timing.
  • Dilution and vesting complexity: The executive's holdings include numerous vesting schedules for restricted stock and options across different years, creating complex future equity events that could influence share supply and executive incentive alignment.

More from Insider Trading

U.S. Antimony Director Jon Marinelli Acquires $93,125 in UAMY Shares Amid Operational Expansion Jun 17, 2026 Saba Capital Trims ECAT Holdings With $1.84M Share Sale Jun 17, 2026 Toro Co CFO Angela Drake Acquires Additional Shares Amidst Recent Earnings Update Jun 17, 2026 Mesa Laboratories Executive Insider Sale and Leadership Transition Jun 17, 2026 Mesa Laboratories CAO Lyndsey Crennen Sells $11,949 in Shares Jun 17, 2026